Alberto Viñals
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alberto Viñals has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Pablo Cabello-García
Department of Medical Physics, Clínica Universidad de Navarra, 28027 Madrid, Spain
2 shared publications - Almudena Zapatero
Radiation Oncology, University Hospital la Princesa, Health Research Institute IIS-IP, Madrid, Spain
1 shared publication - Ana Maria Romero
CIEMAT, Radiation Dosimetry , Avda Complutense 40, 28040 Madrid, Spain
1 shared publication - Ana Navarrete
Department of Radiation Oncology, Clinica Universidad de Navarra, 28027 Madrid, Spain
1 shared publication - Carles Domingo
Universitat Autónoma de Barcelona
1 shared publication - David Hernández González
Servicio de Radiofísica y Protección Radiológica. Hospital Universitario La Princesa. Madrid
1 shared publication
Latest Publications
- Open Access
Salvage Proton Therapy Re-Irradiation in Recurrent Head and Neck Cancer: Outcomes and Adverse Events by Re-Irradiated Target Site
Background/Objectives: Photon re-irradiation in previously treated head and neck cancer (HNC) is constrained by cumulative normal-tissue toxicity. Pencil-beam scanning intensity-modulated proton therapy (PBS-IMPT) allows for a sharper dose conformation than conventional photon techniques, which may widen the therapeutic window in previously irradiated tissue. Methods: Sixty-five patients with recurrent or second primary HNC were enrolled in a prospective single-institution registry and re-irradiated with PBS-IMPT between January 2020 and December 2025. Forty-five were treated with radical intent (69.2%), and 20 were treated postoperatively (30.8%), with a median prescribed dose of 66 Gy (RBE) in 30 fractions. Primary endpoints were overall survival (OS) and progression-free survival (PFS). Locoregional control (LRC), adverse events and the prognostic impact of anatomical extent were secondary endpoints. Results: The median follow-up was 9.3 months. The median OS was 17.2 months (95% CI 13.9–NR), with a 12-month rate of 67.1%. The median PFS was 10.1 months and the median LRC was 28.1 months. Central/skull-base involvement was associated with a non-significant trend toward worse OS (14.3 vs. 35.2 months; p = 0.062) and with significantly worse PFS (9.1 vs. 14.7 months; p = 0.037) than peripheral disease, but LRC did not differ between the groups (p = 0.240). Grade ≥ 3 oral mucositis occurred in 7.7%, with no grade 4–5 acute events. Within a median follow-up of 9.3 months, late osteoradionecrosis affected 6.2%, but late toxicity data remain preliminary given the short follow-up. Ninety-two percent of patients completed treatment. Conclusions: PBS-IMPT re-irradiation provided adequate survival with low acute toxicity. T3–T4 stage at re-irradiation was the only variable retaining significance for PFS on multivariable analysis (HR 4.32, 95% CI 1.24–15.13; p = 0.022). The poor survival observed for central/skull-base disease on Kaplan–Meier curves disappeared after T-stage adjustment, indicating the higher concentration of advanced disease in that compartment. Multicentre prospective data and longer follow-up are needed.
Open AccessSalvage Proton Therapy Re-Irradiation in Recurrent Head and Neck Cancer: Outcomes and Adverse Events by Re-Irradiated Target Site
Background/Objectives: Photon re-irradiation in previously treated head and neck cancer (HNC) is constrained by cumulative normal-tissue toxicity. Pencil-beam scanning intensity-modulated proton therapy (PBS-IMPT) allows for a sharper dose conformation than conventional photon techniques, which may widen the therapeutic window in previously irradiated tissue. Methods: Sixty-five patients with recurrent or second primary HNC were enrolled in a prospective single-institution registry and re-irradiated with PBS-IMPT between January 2020 and December 2025. Forty-five were treated with radical intent (69.2%), and 20 were treated postoperatively (30.8%), with a median prescribed dose of 66 Gy (RBE) in 30 fractions. Primary endpoints were overall survival (OS) and progression-free survival (PFS). Locoregional control (LRC), adverse events and the prognostic impact of anatomical extent were secondary endpoints. Results: The median follow-up was 9.3 months. The median OS was 17.2 months (95% CI 13.9–NR), with a 12-month rate of 67.1%. The median PFS was 10.1 months and the median LRC was 28.1 months. Central/skull-base involvement was associated with a non-significant trend toward worse OS (14.3 vs. 35.2 months; p = 0.062) and with significantly worse PFS (9.1 vs. 14.7 months; p = 0.037) than peripheral disease, but LRC did not differ between the groups (p = 0.240). Grade ≥ 3 oral mucositis occurred in 7.7%, with no grade 4–5 acute events. Within a median follow-up of 9.3 months, late osteoradionecrosis affected 6.2%, but late toxicity data remain preliminary given the short follow-up. Ninety-two percent of patients completed treatment. Conclusions: PBS-IMPT re-irradiation provided adequate survival with low acute toxicity. T3–T4 stage at re-irradiation was the only variable retaining significance for PFS on multivariable analysis (HR 4.32, 95% CI 1.24–15.13; p = 0.022). The poor survival observed for central/skull-base disease on Kaplan–Meier curves disappeared after T-stage adjustment, indicating the higher concentration of advanced disease in that compartment. Multicentre prospective data and longer follow-up are needed.
- Open Access
- 19 July 2025
- Published by Elsevier in Physica Medica
- Vol. 136, 105044
Intercomparison of personal and ambient neutron detectors used for radiation protection in a synchrotron-based proton therapy facility: experimental and Monte Carlo results
- 19 July 2025
- Published by Elsevier in Physica Medica
- Vol. 136, 105044
Open AccessIntercomparison of personal and ambient neutron detectors used for radiation protection in a synchrotron-based proton therapy facility: experimental and Monte Carlo results
- Open Access
- 18 May 2023
- Published by CREIN, S.L. in Revista de Física Médica
- Vol. 24 (1) , 43-50
Análisis de un protocolo de radioterapia guiada por imagen con marcadores fiduciales en radioterapia prostática hipofraccionada
El objetivo principal de este trabajo es el evaluar la validez de un protocolo de radioterapia guiada por imagen (IGRT) implementado en casos de cáncer de próstata con implantación de marcadores fiduciales, así como caracterizar la magnitud de los desplazamientos intrafracción durante las cinco primeras sesiones de un grupo de 32 pacientes tratados a lo largo de un año. Dos semanas antes de la simulación se le implanta al paciente un mínimo de 3 marcadores fiduciales de oro intraprostáticos. Durante el tratamiento, con el uso combinado del sistema Auto Beam Hold (ABH) y la adquisición de imágenes pareadas kV-MV, se analiza el correcto posicionamiento de la zona a tratar y del paciente. De los resultados obtenidos, encontramos que ciertos pacientes acumulan la mayor parte de las interrupciones, lo que apunta a aquéllos que tendrían problemas en el posicionamiento desde el inicio y nos permite valorar la ampliación del seguimiento en determinados casos. Los resultados de los desplazamientos indican que todos los casos requieren correcciones menores de 5 mm. El uso de protocolos de radioterapia guiada por imagen (IGRT) en casos de anatomías variables, representa una mejora en el correcto posicionamiento del paciente y, por consiguiente, en la administración del tratamiento.
- 18 May 2023
- Published by CREIN, S.L. in Revista de Física Médica
- Vol. 24 (1) , 43-50
Open AccessAnálisis de un protocolo de radioterapia guiada por imagen con marcadores fiduciales en radioterapia prostática hipofraccionada
El objetivo principal de este trabajo es el evaluar la validez de un protocolo de radioterapia guiada por imagen (IGRT) implementado en casos de cáncer de próstata con implantación de marcadores fiduciales, así como caracterizar la magnitud de los desplazamientos intrafracción durante las cinco primeras sesiones de un grupo de 32 pacientes tratados a lo largo de un año. Dos semanas antes de la simulación se le implanta al paciente un mínimo de 3 marcadores fiduciales de oro intraprostáticos. Durante el tratamiento, con el uso combinado del sistema Auto Beam Hold (ABH) y la adquisición de imágenes pareadas kV-MV, se analiza el correcto posicionamiento de la zona a tratar y del paciente. De los resultados obtenidos, encontramos que ciertos pacientes acumulan la mayor parte de las interrupciones, lo que apunta a aquéllos que tendrían problemas en el posicionamiento desde el inicio y nos permite valorar la ampliación del seguimiento en determinados casos. Los resultados de los desplazamientos indican que todos los casos requieren correcciones menores de 5 mm. El uso de protocolos de radioterapia guiada por imagen (IGRT) en casos de anatomías variables, representa una mejora en el correcto posicionamiento del paciente y, por consiguiente, en la administración del tratamiento.